Oil Tops $110 as Supply Risks Threaten US Inflation and Energy Stocks
Brent crude reached $110 as supply risks lifted fuel futures, clouded the Fed’s path and offered a potential boost to Canadian energy producers.
CoreWeave’s Credit Market Rout Raises New Questions About AI Infrastructure Risk
CoreWeave’s falling stock, surging bond yields and wider credit default swaps highlight financing ri…
VIX Breaks Above 22 as AI Selloff Raises Stakes for US Stock Traders
The VIX moved above 22 for the first time in four months as AI and chip-stock selling pressured S&P …
Ambarella Draws Possible Third-Bidder Interest as Takeover Speculation Builds
A report of possible third-bidder interest puts Ambarella at the center of fresh takeover speculatio…
Varonis-Proofpoint Deal Puts Cybersecurity Takeover Targets Back in Focus
Proofpoint’s acquisition of Varonis may reinforce expectations for more cybersecurity M&A while resh…
CoreWeave Credit Stress Raises Risk of Wider AI Infrastructure Sell-Off
CoreWeave’s equity and credit-market weakness is testing AI infrastructure sentiment as the VIX rise…
Kimberly-Clark’s Four-Year Weekly Rebound Puts Consumer Staples Back in Focus
Kimberly-Clark is heading for its best week in four years as Q3 developments and progress on a Kenvu…
Truist’s Q3 Earnings Miss and LightStream Sale Put Regional Bank Strategy in Focus
Truist’s Q3 earnings miss, tied partly to a loan sale, and LightStream deal with Carlyle highlight c…
Proofpoint’s $6.3 Billion Varonis Deal Points to a New Cybersecurity M&A Wave
Proofpoint’s $6.3 billion cash deal for Varonis gives markets a clear valuation marker and may signa…
CoreWeave Volatility Tests the Durability of Wall Street’s AI Trade
CoreWeave has become a sentiment bellwether as AI infrastructure stocks sell off, RSI resets and DRA…
Truist’s Q3 Earnings Miss Meets LightStream Sale to Carlyle
Truist’s third-quarter earnings miss, tied to a loan sale, arrives alongside its agreement to sell L…
Labcorp’s $872 Million BioReference Deal Puts Diagnostics Consolidation Back in Focus
Labcorp’s deal for select BioReference assets could expand its diagnostics reach while giving OPKO H…
CCC Intelligent Solutions’ $6.1 Billion Take-Private Deal Sends a Signal Across Software and Insurtech
CCC Intelligent Solutions’ $6.1 billion deal with GTCR and Elliott highlights private-equity demand,…